Antibe Therapeutics Provides 2021 Corporate Update
– Large market partnering program now underway – – Limited COVID-19 impact: Phase III program slated to start in second half of 2021 – – U.S. institutional outreach expanding – TORONTO, CANADA — (January 11, 2021) To our shareholders, As we build on last year’s significant clinical and capital markets achievements and enter the homestretch in … Continued
read
– Large market partnering program now underway – – Limited COVID-19 impact: Phase III program slated to start in second half of 2021 – – U.S. institutional outreach expanding – TORONTO, CANADA — (January 11, 2021) To our shareholders, As we build on last year’s significant clinical and capital markets achievements and enter the homestretch in … Continued